1. Home
  2. CADL vs VINP Comparison

CADL vs VINP Comparison

Compare CADL & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.65

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

N/A

Current Price

$9.90

Market Cap

638.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
VINP
Founded
1999
2009
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
638.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CADL
VINP
Price
$10.65
$9.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$19.00
$14.00
AVG Volume (30 Days)
1.1M
25.3K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
5.72%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$18.07
Revenue Next Year
N/A
$12.74
P/E Ratio
N/A
$24.41
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$9.29
52 Week High
$11.36
$13.61

Technical Indicators

Market Signals
Indicator
CADL
VINP
Relative Strength Index (RSI) 60.63 55.60
Support Level $9.18 $9.49
Resistance Level $11.36 $10.28
Average True Range (ATR) 0.47 0.23
MACD 0.04 0.04
Stochastic Oscillator 87.00 74.07

Price Performance

Historical Comparison
CADL
VINP

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.

Share on Social Networks: